A phase I study of the vascular-disrupting agent BNC105P in combination with gemcitabine-carboplatin in platinum-sensitive ovarian cancer patients in first or second relapse
Rischin, Danny, Beale, Philip James, Rossi, Emma Caroline, Goh, Jeffrey C., Vaughan, Michelle Margaret, Tenney, Meaghan Elizabeth, Martyn, Julie, Sommeijer, Dirkje Willemien, Iglesias, Jose Luis, Kremmidiotis, Gabriel, Simpson, Jeremy Andrew, Doolin, Elizabeth E., Lavranos, Tina C., Leske, Annabell F., Veillard, Anne-Sophie, Stockler, Martin R.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC) patients: Updated phase I results of the Disruptor-1 trial
Sarantopoulos, John, Dang, Long H., Lauer, Richard C., Starodub, Alexander, Hauke, Ralph J., Galsky, Matt D., Bylow, Kathryn A., Cowey, Charles Lance, Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Lavranos, Tina C., Iglesias, Jose Luis, Sonpavde, Guru, Logan, Theodore, Hahn, Noah M., Sweeney, Christopher, Hutson, Thomas E.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Updated phase I results of a phase I/II trial of BNC105P with everolimus in patients with metastatic renal cell carcinoma (mRCC)
Hutson, Thomas E., Dang, Long H., Lauer, Richard C., Starodub, Alexander, Hauke, Ralph J., Galsky, Matt D., Bylow, Kathryn A., Cowey, Charles Lance, Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Lavranos, Tina C., Sonpavde, Guru, Logan, Theodore, Hahn, Noah M., Sweeney, Christopher, Sarantopoulos, John
Published in Journal of clinical oncology (20.02.2013)
Published in Journal of clinical oncology (20.02.2013)
Get full text
Journal Article
Discovery of 7-hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzobfuran (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties
Flynn, Bernard L, Gill, Gurmit S, Grobelny, Damian W, Chaplin, Jason H, Paul, Dharam, Leske, Annabell F, Lavranos, Tina C, Chalmers, David K, Charman, Susan A, Kostewicz, Edmund, Shackleford, David M, Morizzi, Julia, Hamel, Ernest, Jung, M Katherine, Kremmidiotis, Gabriel
Published in Journal of medicinal chemistry (08.09.2011)
Published in Journal of medicinal chemistry (08.09.2011)
Get full text
Journal Article
Phase I results of a phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC) patients previously treated with VEGFR tyrosine kinase inhibitors
Hutson, Thomas E., Dang, Long H., Lauer, Richard C., Starodub, Alexander, Hauke, Ralph J., Galsky, Matt D., Bylow, Kathryn A., Logan, Theodore, Cowey, Charles Lance, Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Lavranos, Tina C., Sonpavde, Guru, Hahn, Noah M., Sweeney, Christopher, Sarantopoulos, John
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Phase II trial of BNC105P as second-line chemotherapy for advanced malignant pleural mesothelioma (MPM): Australasian Lung Cancer Trials Group and NHMRC Clinical Trials Centre Collaboration
Nowak, Anna K., Brown, Chris, Millward, Michael, Hughes, Brett Gordon Maxwell, Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Mitchell, Paul, Pavlakis, Nick, Coskinas, Xanthi, Sebastian, Lucille T, Cummins, Michelle M, Boyer, Michael J., Parnis, Francis, Lavranos, Tina C., Stockler, Martin R.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Abstract 2498: BNC105 is a tubulin polymerization inhibitor that exhibits vascular disruptive activity in renal cancer and causes upregulation in HIF1alpha, HIF2alpha and mTOR
Leske, Annabell F., Beaumont, Donna M., Lavranos, Tina C., Gasic, Jelena, Coles, Carolyn J., Matthews, Clayton A., Phillips, Renee J., Kremmidiotis, Gabriel
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article
Phase I/II study of a BNC105P/everolimus regimen for progressive metastatic renal cell carcinoma (mRCC) following prior tyrosine kinase inhibitors (Hoosier Oncology Group)
Hutson, Thomas E., Dang, Long H., Lauer, Richard C., Starodub, Alexander, Hauke, Ralph J., Logan, Theodore, Bylow, Kathryn A., Galsky, Matt D., Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Lavranos, Tina C., Leske, Annabell F., Hahn, Noah M., Sonpavde, Guru, Sweeney, Christopher, Sarantopoulos, John
Published in Journal of clinical oncology (10.02.2012)
Published in Journal of clinical oncology (10.02.2012)
Get full text
Journal Article
Distribution of the α1 to α6 chains of type IV collagen in bovine follicles
RODGERS, H. F, IRVINE, C. M, VAN WEZEL, I. L, LAVRANOS, T. C, LUCK, M. R, SADO, Y, NINOMIYA, Y, RODGERS, R. J
Published in Biology of reproduction (1998)
Published in Biology of reproduction (1998)
Get full text
Journal Article
Anchorage-Independent Culture of Bovine Granulosa Cells: The Effects of Basic Fibroblast Growth Factor and Dibutyryl cAMP on Cell Division and Differentiation
Lavranos, Tina C., Rodgers, Helen F., Bertoncello, Ivan, Rodgers, Raymond J.
Published in Experimental cell research (01.04.1994)
Published in Experimental cell research (01.04.1994)
Get full text
Journal Article
Evidence for Ovarian Granulosa Stem Cells: Telomerase Activity and Localization of the Telomerase Ribonucleic Acid Component in Bovine Ovarian Follicles1
Lavranos, Tina C., Mathis, J. Michael, Latham, Sue E., Kalionis, Bill, Shay, Jerry W., Rodgers, Raymond J.
Published in Biology of reproduction (01.08.1999)
Published in Biology of reproduction (01.08.1999)
Get full text
Journal Article